Centessa Pharmaceuticals Stock Quote 0ACX - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

0.00

Open

Last Trade

16.61

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

0.00

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

6.85M

Net Profit

-151.09M

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.centessa.com

Headquarters

Cheshire, Gbr

Founded

Centessa Pharmaceuticals Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker 0ACX. The last closing price for Centessa Pharmaceuticals was $0. Over the last year, Centessa Pharmaceuticals shares have traded in a share price range of $ 0.00 to $ 0.00.

Centessa Pharmaceuticals currently has 0 shares outstanding.

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a...

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares BOSTON and LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals...

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares BOSTON and LONDON, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq:...

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers 2.5 mg dose restored normative...

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep...

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024 Company advancing pipeline of potential best-in-class orexin receptor 2 (OX2R) agonists...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PPSProton Motor Power Systems Plc	0.55p (83.33%)	5.86M
CADCadogan Energy Solutions Plc	4.25p (77.08%)	14.62M
KZGKazera Global Plc	1.525p (35.56%)	89.49M
WEBWebis Holdings Plc	0.125p (19.05%)	4.67M
PETPetrel Resources Plc	1.35p (17.39%)	1.43M
MILAMila Resources Plc	0.35p (-30.00%)	33.37M
IPXImpax Asset Management Group Plc	250.00p (-23.66%)	3.14M
RNEPEcofin U.s. Renewables Infrastructure Trust Plc	26.20p (-19.88%)	21.5k
PMPPortmeirion Group Plc	174.00p (-15.12%)	58.93k
ROCKRockfire Resources Plc	0.165p (-13.16%)	190.11M
NTVONativo Resources Plc	0.0024p (0.00%)	967.12M
TRPTower Resources Plc	0.027p (1.89%)	481.24M
VRSVersarien Plc	0.034p (11.48%)	374.02M
ORCPOracle Power Plc	0.0315p (-11.27%)	305M
CPXCap-xx Limited	0.145p (0.00%)	260.82M